Company intelligence / Profile preview

RBNA

Slough, United Kingdom
Ownership
Private
Employees
~40000
Development stage
Other
01

Overview

Reckitt is a global leader in consumer health, hygiene, and nutrition, operating a vast portfolio of well-known brands including Mucinex, Gaviscon, Nurofen, and Enfamil. The company focuses on providing innovative solutions for everyday health needs, ranging from over-the-counter (OTC) medications for respiratory and gastrointestinal relief to specialized infant and adult nutrition products. Reckitt's business is structured around three primary global business units: Health, Hygiene, and Nutrition, with a significant presence in North America through its RBNA division. The company is committed to sustainable growth and scientific excellence, maintaining a robust pipeline of product enhancements and new formulations to address evolving consumer wellness trends.

Therapeutic areas
NeurologyInfectious DiseasesPulmonologyGastroenterologyMetabolic Disorders
Modalities
Small moleculeBiologicNutraceutical
Industry
Pharma
02

Partnerships

Bayer (historical)Bristol Myers Squibb (historical OTC assets)

Beyond the preview

Go deeper on RBNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RBNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call